Microdosing GLP-1 Receptor Agonists During Perimenopause: A Clinical Approach to Hormonal Weight Gain Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC Perimenopause represents a challenging time for women, with up to 70% experiencing weight gain due to declining estrogen levels, decreased energy expenditure, and metabolic changes
Ces mdicaments sont parfois dtourns pour la perte de poids des fins esthtiques et non de sant
Changes in eating habits: You may find yourself eating smaller meals, different foods, or higher-protein optionssome of which are naturally gas-producing
Life Sciences 51(13):1049-1056. [doi.org]
Sim R, Hernndez C
Choose based on side effect profile and lifestyle